1. Home
  2. CRAI vs HROW Comparison

CRAI vs HROW Comparison

Compare CRAI & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRAI
  • HROW
  • Stock Information
  • Founded
  • CRAI 1965
  • HROW 1998
  • Country
  • CRAI United States
  • HROW United States
  • Employees
  • CRAI N/A
  • HROW N/A
  • Industry
  • CRAI Other Consumer Services
  • HROW Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRAI Consumer Discretionary
  • HROW Health Care
  • Exchange
  • CRAI Nasdaq
  • HROW Nasdaq
  • Market Cap
  • CRAI 1.3B
  • HROW 1.4B
  • IPO Year
  • CRAI 1998
  • HROW N/A
  • Fundamental
  • Price
  • CRAI $198.17
  • HROW $39.42
  • Analyst Decision
  • CRAI Buy
  • HROW Strong Buy
  • Analyst Count
  • CRAI 1
  • HROW 7
  • Target Price
  • CRAI $228.00
  • HROW $64.67
  • AVG Volume (30 Days)
  • CRAI 78.9K
  • HROW 486.7K
  • Earning Date
  • CRAI 10-30-2025
  • HROW 11-12-2025
  • Dividend Yield
  • CRAI 0.99%
  • HROW N/A
  • EPS Growth
  • CRAI 44.21
  • HROW N/A
  • EPS
  • CRAI 8.27
  • HROW N/A
  • Revenue
  • CRAI $712,913,000.00
  • HROW $227,661,000.00
  • Revenue This Year
  • CRAI $9.01
  • HROW $45.86
  • Revenue Next Year
  • CRAI $4.26
  • HROW $41.41
  • P/E Ratio
  • CRAI $23.98
  • HROW N/A
  • Revenue Growth
  • CRAI 9.28
  • HROW 47.69
  • 52 Week Low
  • CRAI $152.57
  • HROW $20.85
  • 52 Week High
  • CRAI $214.01
  • HROW $59.23
  • Technical
  • Relative Strength Index (RSI)
  • CRAI 58.22
  • HROW 59.01
  • Support Level
  • CRAI $191.56
  • HROW $35.62
  • Resistance Level
  • CRAI $198.89
  • HROW $40.33
  • Average True Range (ATR)
  • CRAI 4.44
  • HROW 1.61
  • MACD
  • CRAI -0.01
  • HROW -0.03
  • Stochastic Oscillator
  • CRAI 73.46
  • HROW 67.50

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: